首页> Vaccine> Immunogenicity and safety of the human rotavirus vaccine Rotarix (TM) co-administered with routine infant vaccines following the vaccination schedules in Europe

Immunogenicity and safety of the human rotavirus vaccine Rotarix (TM) co-administered with routine infant vaccines following the vaccination schedules in Europe

导出原文传递

翻译打印收藏纠错

作者： Vesikari, Timo ^[1] ; Karvonen, Aino ^[2] ; Prymula, Roman ^[3] ; Schuster, Volker ^[4] ; Tejedor, Juan C. ^[5] ; Thollot, Franck ^[6] ; Garcia-Corbeira, Pilar ; Damaso, Silvia ; Han, Htay-Htay ; Bouckenooghe, Alain .

作者单位： GlaxoSmithKline Biologicals, Rixensart, Belgium ^[1] Children’s Hospital, University Hospital, Leipzig, Germany ^[2] University of Tampere, Medical School, FIN-33014 Tampere, Finland ^[3] Medical Facility, Essey les Nancy, France ^[4] Hospital de Móstoles, Madrid, Spain ^[5] Faculty of Military Health Sciences, University of Defense, Hradec Králové, Czech Republic ^[6]

发布时间 2014-02-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

Vaccine

2010年28卷32期

5272-5279页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Immunogenicity and safety of the human rotavirus vaccine Rotarix (TM) co-administered with routine infant vaccines following the vaccination schedules in Europe

Vaccine

相似文献

Vaccine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Immunogenicity and safety of the human rotavirus vaccine Rotarix (TM) co-administered with routine infant vaccines following the vaccination schedules in Europe

Vaccine

相似文献

Vaccine

相关期刊

检索历史清除